Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci | Zendy

D. M. Livermore | Zendy; Shazad Mushtaq | Zendy; M. Warner | Zendy; N. Woodford | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci

Author(s) -

D. M. Livermore,

Shazad Mushtaq,

M. Warner,

N. Woodford

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp002

Subject(s) - linezolid , enterococcus faecium , 23s ribosomal rna , microbiology and biotechnology , enterococcus , agar dilution , minimum inhibitory concentration , staphylococcus aureus , enterococcus faecalis , antibiotics , chemistry , biology , bacteria , vancomycin , biochemistry , rna , gene , genetics , ribosome

TR-700 is the active moiety of TR-701 (DA-7157), a new oral/intravenous oxazolidinone prodrug. We examined its activity against linezolid-susceptible and -resistant staphylococci and enterococci.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research